Table 1 |
||||
|
Number of genes called significant at 10% false discovery rate on isogenic biologic replicates |
||||
|
Statistic |
Embryoid blast |
Myeloid |
||
|
|
||||
|
4 hours |
24 hours |
4 hours |
24 hours |
|
|
|
||||
|
Standard t (scheme 1) |
32 |
8,038 |
7,154 |
331 |
|
Cyber t (scheme 2) |
1,288 |
9,769 |
10,349 |
4,464 |
|
Scheme 4 |
90 |
87 |
268 |
38 |
|
SAM |
4,954 |
14,239 |
16,644 |
9,392 |
|
|
||||
|
Each entry in this table is the number of significant genes when comparing treatment (DMSO + drug) with control (just DMSO) for a cell type (embryoid blast or myeloid) and a time point (4 or 24 hours). All data were subject to quantile-quantile normalization and summarized using RMA. The Benjamini and Hochberg algorithm was used on P values generated by the standard t test, cyber t, and scheme 4 to calculate false discovery rate. The values for SAM were generated by the TIGR Multiple Array Viewer (see Materials and methods) with 100 permutations and the default parameters. DMSO, dimethyl sulfoxide; RMA, Robust Multichip Average; SAM, significance analysis of microarrays. |
||||
|
Fodor et al. Genome Biology 2007 8:R69 doi:10.1186/gb-2007-8-5-r69 |
||||